Public Health Agency of Canada
www.publichealth.gc.ca
Home > STD Self Directed Learning Module > Canadian STI Guidelines > Pages 136-137:
Treatment - Youth and adults
-
Agency Information
-
Diseases & Conditions
-
Health & Safety
-
Research & Statistics
-
Agency Information
-
Transparency
Search Box
To share this page just click on the social network icon of your choice.
Canadian STI Guidelines
Pages 136-137: Treatment - Youth and adults
Urethral, Endocervical, Rectal
Infection
(except in pregnant women and nursing
mothers) |
Pelvic inflammatory disease, see page 80
Epididymitis, see page 100 |
Preferred:
- Azithromycin 1 g orally in a single
dose(a)
|
Alternative:
- Doxycycline 100 mg orally bid for 7 days
Other alternatives:
- Ofloxacin 300 mg bid
for 7 days
OR
- Erythromycin 2 g/day orally in divided doses for 7
days(b)
OR
- Erythromycin 1 g/day orally in divided doses for 14
days(b)
|
Notes:
(a) If
vomiting occurs more than one hour post administration, a repeat
dose is not required.
(b) Erythromycin dosages refer to the use of erythromycin base.
Equivalent dosages of other formulations (EXCEPT the estolate which
is contraindicated in pregnancy) may be substituted. If
erythromycin has been used for treatment, repeat testing after
completion of therapy is advisable. |
Urethral, Endocervical, Rectal
Infection in Pregnant Women and Nursing Mothers |
Preferred:
OR |
Alternative: |
Notes:
(a)
Erythromycin dosage refers to the use of erythromycin base.
Equivalent dosages of other formulations (EXCEPT the estolate which
is contraindicated in pregnancy) may be substituted. If
erythromycin or amoxicillin has been used for treatment, repeat
testing after completion of therapy is advisable.
(b) To date, there are limited data collected on azithromycin in
pregnancy but it is considered to be safe in this context by many
experts. |
To share this page just click on the social network icon of your choice.